Aktis Oncology AKTS
NASDAQ AKTS
$16.62 +0.34 (+2.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Aktis Oncology (AKTS) Assets (2024 - 2026)

Updated

Aktis Oncology's Assets came in at $532.48 million for Q3 2026, down 4.5% from the prior quarter.

Analysis

Aktis Oncology (AKTS) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Aktis Oncology's Assets was $264.89 million, down 18.8% from FY2024.

  • Going back by year, Assets was $326.18 million in FY2024.
  • The five-year range for quarterly Assets is $264.89 million (Q4 2025) to $576.8 million (Q1 2026).
  • Business Quant data shows AKTS's Assets at $557.6 million (Q2 2026), $576.8 million (Q1 2026) and $264.89 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 197.43 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 147.68 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 205.00 Bn
10 Aktis Oncology 895.95 Mn 335.72 Mn - 532.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 532.48 Mn
Jun 30, 2026 557.60 Mn
Mar 31, 2026 576.80 Mn
Dec 31, 2025 264.89 Mn
Dec 31, 2024 326.18 Mn
API Access

Aktis Oncology Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=AKTS&period=max&api_key=YOUR_API_KEY